Stifel Financial’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.5M | Buy |
49,954
+29,527
| +145% | +$10M | 0.02% | 715 |
|
|
2025
Q4 | $8.12M | Buy |
20,427
+132
| +0.7% | +$58.4K | 0.01% | 1069 |
|
|
2025
Q3 | $9.25M | Buy |
20,295
+6,595
| +48% | +$2.69M | 0.01% | 986 |
|
|
2025
Q2 | $4.47M | Buy |
13,700
+6,627
| +94% | +$1.83M | ﹤0.01% | 1310 |
|
|
2025
Q1 | $1.91M | Sell |
7,073
-2,944
| -29% | -$757K | ﹤0.01% | 1790 |
|
|
2024
Q4 | $2.36M | Buy |
10,017
+4,187
| +72% | +$1.1M | ﹤0.01% | 1650 |
|
|
2024
Q3 | $1.6M | Sell |
5,830
-109
| -2% | -$28.4K | ﹤0.01% | 1918 |
|
|
2024
Q2 | $1.44M | Sell |
5,939
-2,401
| -29% | -$379K | ﹤0.01% | 1946 |
|
|
2024
Q1 | $1.25M | Sell |
8,340
-3,318
| -28% | -$553K | ﹤0.01% | 2050 |
|
|
2023
Q4 | $2.23M | Buy |
11,658
+3,589
| +44% | +$611K | ﹤0.01% | 1588 |
|
|
2023
Q3 | $1.43M | Sell |
8,069
-1,253
| -13% | -$239K | ﹤0.01% | 1808 |
|
|
2023
Q2 | $1.77M | Buy |
9,322
+1,611
| +21% | +$319K | ﹤0.01% | 1714 |
|
|
2023
Q1 | $1.54M | Buy |
7,711
+261
| +4% | +$54.9K | ﹤0.01% | 1743 |
|
|
2022
Q4 | $1.77M | Sell |
7,450
-2,807
| -27% | -$599K | ﹤0.01% | 1607 |
|
|
2022
Q3 | $2.05M | Buy |
10,257
+673
| +7% | +$128K | ﹤0.01% | 1454 |
|
|
2022
Q2 | $1.4M | Sell |
9,584
-2,592
| -21% | -$368K | ﹤0.01% | 1750 |
|
|
2022
Q1 | $1.99M | Sell |
12,176
-2,500
| -17% | -$381K | ﹤0.01% | 1617 |
|
|
2021
Q4 | $2.49M | Buy |
14,676
+674
| +5% | +$125K | ﹤0.01% | 1462 |
|
|
2021
Q3 | $2.64M | Sell |
14,002
-8,775
| -39% | -$1.65M | ﹤0.01% | 1395 |
|
|
2021
Q2 | $3.86M | Buy |
22,777
+2,530
| +12% | +$371K | 0.01% | 1157 |
|
|
2021
Q1 | $2.86M | Buy |
20,247
+4,207
| +26% | +$633K | ﹤0.01% | 1288 |
|
|
2020
Q4 | $2.08M | Buy |
16,040
+1,310
| +9% | +$175K | ﹤0.01% | 1363 |
|
|
2020
Q3 | $2.14M | Buy |
14,730
+1,288
| +10% | +$183K | ﹤0.01% | 1179 |
|
|
2020
Q2 | $1.99M | Buy |
13,442
+7,116
| +112% | +$959K | ﹤0.01% | 1162 |
|
|
2020
Q1 | $689K | Buy |
6,326
+1,639
| +35% | +$189K | ﹤0.01% | 1656 |
|
|
2019
Q4 | $539K | Buy |
4,687
+603
| +15% | +$60.1K | ﹤0.01% | 2204 |
|
|
2019
Q3 | $328K | Buy |
4,084
+114
| +3% | +$9.02K | ﹤0.01% | 2399 |
|
|
2019
Q2 | $288K | Buy |
3,970
+1,496
| +60% | +$115K | ﹤0.01% | 2524 |
|
|
2019
Q1 | $232K | Buy |
+2,474
| New | +$207K | ﹤0.01% | 2519 |
|
|
2015
Q3 | – | Sell |
-3,807
| Closed | -$456K | – | 2251 |
|
|
2015
Q2 | $456K | Buy |
3,807
+173
| +5% | +$20.7K | ﹤0.01% | 1732 |
|
|
2015
Q1 | $379K | Buy |
+3,634
| New | +$368K | ﹤0.01% | 1774 |
|
Other funds holding ALNY
VPM
VCM
